2024 MSKCC Cardio-Oncology Symposium — On Demand

On May 2—3, 2024, an interdisciplinary group of cardiology and oncology experts from Memorial Sloan Kettering Cancer Center and around the world, presented the latest research and contemporary practice strategies in the prevention, early diagnosis, and management of cardiovascular disease in cancer patients and cancer survivors at the 2024 MSK Cardio-Oncology Symposium. We’re excited to offer this state-of-the-art, comprehensive, case-based curriculum available for purchase on demand.

Advances in cancer therapeutics have significantly improved cancer survival. With cancer mortality decreasing, cardiovascular disease has emerged as a formidable competing cause of death. Cancer survivors now demonstrate 2-5 times higher mortality risk due to cardiovascular disease than the general population, threatening to limit the gains achieved in cancer survival. In response to the growing concerns about the cardiovascular challenges faced by patients with cancer, the field of Cardio-Oncology has evolved, consisting of experts in both cancer and cardiovascular medicine working to improve the detection, monitoring, and treatment of cardiovascular disease at each stage of the cancer care continuum. The field is rapidly growing to meet the urgent need to improve the cardiovascular health of patients with cancer.

This symposium highlights the most cutting-edge and trending subjects in the rapidly evolving field of Cardio-Oncology, ensuring participants gain insights into the latest advancements shaping the future of cardiovascular care for cancer patients.